CSPC Innovation Pharmaceutical News

New Novus: Announcement on the signing of an exclusive cooperation agreement for SYS6005 between the holding subsidiary and Radiance BioPharma

Feb 18 18:52 ET

New Novus: Announcement on the progress of implementation of the controlling shareholder\'s plan to increase the company\'s share holdings and the increase time for more than half of the time

Feb 10 03:52 ET

Novus: Announcement on the holding subsidiary obtaining a drug registration certificate for new indications of injectable omalizumab

Feb 10 02:46 ET

New Novus: Announcement on the holding subsidiary SYS6017 shingles mRNA vaccine receiving approval notice for drug clinical trials

Feb 7 03:14 ET

New Novus: Progress Announcement on the Use of Some Idle Raised Funds for Cash Management

Jan 21 02:42 ET

New Novus: Special inspection opinions of SDIC Securities Co., Ltd. and CITIC Securities Co., Ltd. on the Shenzhen Stock Exchange\'s response to the Shenzhen Stock Exchange\'s “Application for Issuance of Shares to Purchase Assets and Raise Supporting Funds”

Jan 19 18:48 ET

New Novus: Response from CSPC Pharmaceutical Co., Ltd. to the Shenzhen Stock Exchange\'s “Review Inquiry Letter on the Application of CSPC Pharmaceutical Co., Ltd. to Issue Shares to Purchase Assets and Raise Supporting Funds”

Jan 19 18:48 ET

New Novus: Response from Xinyong Zhonghe Certified Public Accountants (Special General Partnership) to the Shenzhen Stock Exchange\'s “Review Inquiry Letter on the Application for Issuance of Shares by Shiyao Innovative Pharmaceutical Co., Ltd. to Purchase Assets and Raise Supporting Funds”

Jan 19 18:48 ET

New Novus: Report on Issuing Shares and Paying Cash to Purchase Assets and Raise Supporting Funds and Related Transactions (Draft) (Revised Draft)

Jan 19 18:48 ET

New Novus: Beijing China Enterprise China Asset Appraisal Co., Ltd.\'s response to the Shenzhen Stock Exchange\'s “Review and Inquiry Letter on the Application for Issuance of Shares by Shiyao Innovative Pharmaceutical Co., Ltd. to Purchase Assets and Raise Supporting Funds”

Jan 19 18:48 ET

New Novus: CSPC Pharmaceutical Co., Ltd. issues shares and pays cash to purchase assets and raise supporting capital and related transactions (draft) summary (revised draft)

Jan 19 18:48 ET

New Novus: Beijing Junzejun Law Firm\'s Supplementary Legal Opinion on the Issuance of Shares by Shiyao Innovative Pharmaceutical Co., Ltd. and the Payment of Cash to Purchase Assets and Raise Supporting Funds and Related Transactions (1)

Jan 19 18:48 ET

New Novus: Announcement of CSPC Pharmaceutical Co., Ltd.\'s revised instructions on issuing shares and paying cash to purchase assets and raise supporting capital and related transactions (draft) (revised draft)

Jan 19 18:48 ET

New Novus: Independent Financial Advisory Report of SDIC Securities Co., Ltd. and CITIC Securities Co., Ltd. on the issuance of shares by Shiyao Innovative Pharmaceutical Co., Ltd. and the payment of cash to purchase assets and raise supporting capital and related transactions (revised draft)

Jan 19 18:48 ET

New Novus: 2024 performance forecast

Jan 17 06:27 ET

New Novus: Announcement on the holding subsidiary SYS6043 antibody-conjugated drug being approved for US drug clinical trials

Jan 16 02:46 ET

New Novus: Announcement on the holding subsidiary SYS6041 antibody-conjugated drug obtaining approval notice for drug clinical trials

Jan 10 02:50 ET

New Novus: Announcement of Resolutions of the 2025 First Extraordinary General Meeting of Shareholders

Jan 8 04:02 ET

New Novus: Legal Opinion of Beijing Junzejun Law Firm on Witnessing the 2025 First Extraordinary General Meeting of Shareholders of Shiyao Innovative Pharmaceutical Co., Ltd.

Jan 8 04:02 ET

New Novus: Announcement on the holding subsidiary SYS6045 antibody drug conjugate obtaining approval notice for drug clinical trials

Jan 7 02:42 ET